Keyphrases
High Risk
100%
Clinical Utility
100%
Confidence Interval
100%
Lung Cancer Risk
100%
Aneusomy
100%
Sputum
55%
Positive Likelihood Ratio
44%
Colorado
33%
Fluorescence in Situ Hybridization
33%
High-risk Population
22%
Negative Likelihood Ratio
22%
Risk Stratification
11%
Longitudinal Assessment
11%
Nested Case-control Study
11%
Lung Cancer
11%
Non-invasive Biomarkers
11%
Screening Study
11%
Centromere
11%
Sensitivity Specificity
11%
PIK3CA
11%
Pittsburgh
11%
Nodule
11%
False Positive Rate
11%
Radiograph
11%
Lung Screening
11%
Receiver Operating Characteristic Analysis
11%
Target DNA
11%
Screening Population
11%
High-risk Areas
11%
Low Positive
11%
5p15
11%
Low-dose Computed Tomography
11%
National Lung Screening Trial
11%
MYC Gene
11%
Low-dose Computed Tomography Screening
11%
Pulmonary Nodule
11%
American College of Radiology
11%
Fluorescence in Situ Hybridization Assay
11%
Category Scale
11%
Indeterminate Pulmonary Nodules
11%
Myelocytomatosis Oncogene
11%
V-myc
11%
Indeterminate Nodules
11%
Ratio Limit
11%
5-bisphosphate 3-kinase Catalytic Subunit α
11%
Fibroblast Growth Factor 1 (FGF1)
11%
Screening for Lung Cancer
11%
Imaging Network
11%
α Gene
11%
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
11%
Medicine and Dentistry
Lung Cancer
100%
Sputum
100%
Fluorescence in Situ Hybridization
80%
Biological Marker
40%
Low Drug Dose
40%
Computer Assisted Tomography
40%
Sensitivity and Specificity
40%
False Positive Result
40%
Lung Nodule
40%
Lung
20%
Myeloid Leukemia
20%
Risk Stratification
20%
Radiology
20%
Enzyme Active Site
20%
Epidermal Growth Factor Receptor
20%
Virus Oncogene
20%
National Lung Screening Trial
20%
Phosphatidylinositol 4,5 Bisphosphate 3 Kinase
20%
Fibroblast Growth Factor 1
20%
Case-Control Study
20%
Alpha Chain
20%
Centromere
20%
Biochemistry, Genetics and Molecular Biology
Fluorescence in Situ Hybridization
100%
Computer Assisted Tomography
50%
Low Drug Dose
50%
Centromere
25%
Case-Control Study
25%
Alpha Chain
25%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
25%
Bird
25%
Enzyme Active Site
25%
Myc
25%
Virus Oncogene
25%
Epidermal Growth Factor Receptor
25%
Fibroblast Growth Factor
25%
Fibrinogen
25%